The Uighur Crisis: What BGI Is Doing About It

In 2010, after receiving $1.5 billion from China's government, BGI was able to expand dramatically. Under a series of laws unthinkable in Western democracies, Chinese companies like BGI are obligated to share data with the Chinese regime. As BGI touts on its own website, the company has been steadily developing partnerships with hospitals and biotech companies inside the United States. The financial stakes for dominating the global biotech sector is estimated to be worth up to $4 trillion a year.